Pregnancy-Associated Osteoporosis Presented with Femoral Neck Fracture: A Case Report and Literature Review

被引:1
作者
Faraji, Azam [1 ]
Shomali, Zahra [2 ]
Yoosefi, Sedigeh [3 ]
机构
[1] Shiraz Univ Med Sci, Maternal Fetal Med Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Med Sch, Obstet & Gynaecol Dept, Shiraz, Iran
[3] Shiraz Univ Med Sci, Maternal Fetal Med Res Ctr, Perinatol Dept, Shiraz, Iran
来源
GALEN MEDICAL JOURNAL | 2020年 / 9卷
关键词
Osteoporosis; Pregnancy; Fracture; Femur;
D O I
10.31661/gmj.v9i0.1750
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Pregnancy-associated osteoporosis (PAO) is a rare condition characterized by reduced bone mineral density during the third trimester or lactation. Multiple risk factors, such as genetic, sedentariness, and 25-hydroxy vitamin D deficiency, are associated with PAO. In the majority of cases, PAO is presented with a compression fracture in vertebras, but in our case, it presented with a fracture of the femoral neck. Case Presentation: A 29-year-old, gravida one woman, developed right hip joint pain during the gestational age 34 weeks who referred to our clinic. Despite conservative management, the pain intensified. The patient delivered a healthy neonate in the 38th week of gestation and afterward underwent magnetic resonance imaging of the pelvic, revealing a bruised bone in the femoral neck. Since she had developed a femoral neck fracture during the postpartum period, she underwent open reduction and fixation of the femoral neck. Dual-energy X-ray absorptiometry (DEXA) revealed osteoporosis of the vertebras and femoral neck. She received calcium supplements and alendronate, and the pain was relieved. On 2-year and 4-year follow-up, she was found to be osteopenic with significant improvement in DEXA indices. Conclusion: PAO is a rare condition among young women. This condition should be kept in mind when hip joint or back pain is encountered during pregnancy.
引用
收藏
页数:5
相关论文
共 13 条
[1]  
Becker C.B CA, 2018, EVALUATION TREATMENT
[2]   Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2 [J].
Butscheidt, S. ;
Delsmann, A. ;
Rolvien, T. ;
Barvencik, F. ;
Al-Bughaili, M. ;
Mundlos, S. ;
Schinke, T. ;
Amling, M. ;
Kornak, U. ;
Oheim, R. .
OSTEOPOROSIS INTERNATIONAL, 2018, 29 (07) :1643-1651
[3]   PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report [J].
Eller-Vainicher, Cristina ;
Ossola, Manuela Wally ;
Beck-Peccoz, Paolo ;
Chiodini, Iacopo .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (04) :753-756
[4]  
EM L, 2017, OVERVIEW DUAL ENERGY
[5]  
Gary Cunningham F., 2018, CASEY WILLIAMS OBSTE, V25 th, P2503
[6]   The use of i. v. bisphosphonate in pregnancy-associated osteoporosis - Case study [J].
Hellmeyer, L. ;
Kuehnert, M. ;
Ziller, V. ;
Schmidt, S. ;
Hadji, P. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (02) :139-142
[7]   Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis [J].
Li, Lu-jiao ;
Zhang, Jia ;
Gao, Peng ;
Lv, Fang ;
Song, Yu-wen ;
Chang, Xiao-yan ;
Zhao, Di-chen ;
Wang, Ou ;
Jiang, Yan ;
Xing, Xiao-ping ;
Xia, Wei-bo ;
Li, Mei .
CLINICAL RHEUMATOLOGY, 2018, 37 (11) :3141-3150
[8]  
NORDIN BEC, 1955, LANCET, V1, P431
[9]   Bisphosphonates in pregnancy and lactation-associated osteoporosis [J].
O'Sullivan, SM ;
Grey, AB ;
Singh, R ;
Reid, IR .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (07) :1008-1012
[10]   Severe postpartum osteoporosis with increased PTHrP during lactation in a patient after total thyroidectomy and parathyroidectomy [J].
Segal, E. ;
Hochberg, I. ;
Weisman, Y. ;
Ish-Shalom, S. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (11) :2907-2911